Laurence L Greenhill

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology
    Laurence L Greenhill
    New York State Psychiatric Institute, Columbia University, USA
    J Am Acad Child Adolesc Psychiatry 43:1488-96. 2004
  2. ncbi request reprint Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine
    Laurence L Greenhill
    The New York State Psychiatric Institute Columbia University, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 46:566-72. 2007
  3. doi request reprint Attention deficit hyperactivity disorder in preschool children
    Laurence L Greenhill
    Department of Psychiatry, New York State Psychiatric Institute, Unit 78, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Child Adolesc Psychiatr Clin N Am 17:347-66, ix. 2008
  4. ncbi request reprint Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Desiree W Murray
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Child Adolesc Psychopharmacol 17:605-20. 2007
  5. ncbi request reprint Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Howard B Abikoff
    New York University Child Study Center, 215 Lexington Avenue, New York, NY 10016, USA
    J Child Adolesc Psychopharmacol 17:581-92. 2007
  6. ncbi request reprint Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Kelly Posner
    New York State Psychiatric Institute Columbia University, 1041 Riverside Drive, New York, NY 10032, USA
    J Child Adolesc Psychopharmacol 17:547-62. 2007
  7. doi request reprint Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment
    Elizabeth Pappadopulos
    Columbia University, USA
    J Am Acad Child Adolesc Psychiatry 48:501-10. 2009
  8. ncbi request reprint Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000
    Laurence L Greenhill
    New York State Psychiatric Institute, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:651-5. 2003
  9. pmc A double-blind, placebo-controlled study of atomoxetine in young children with ADHD
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, 985581 Nebraska Medical Center, Omaha, NE 68198 5581, USA
    Pediatrics 127:e862-8. 2011
  10. ncbi request reprint 3-year follow-up of the NIMH MTA study
    Peter S Jensen
    Center for the Advancement of Children s Mental Health, Unit 78, Columbia University NYSPI, 1051 Riverside Drive, New York, NY 10027, USA
    J Am Acad Child Adolesc Psychiatry 46:989-1002. 2007

Detail Information

Publications66

  1. ncbi request reprint Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology
    Laurence L Greenhill
    New York State Psychiatric Institute, Columbia University, USA
    J Am Acad Child Adolesc Psychiatry 43:1488-96. 2004
    ..To improve the gathering of adverse events (AEs) in pediatric psychopharmacology by examining the value and acceptability of increasingly detailed elicitation methods...
  2. ncbi request reprint Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine
    Laurence L Greenhill
    The New York State Psychiatric Institute Columbia University, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 46:566-72. 2007
    ..To compare the effects of two different methods for initiating atomoxetine in terms of the incidence of early adverse events...
  3. doi request reprint Attention deficit hyperactivity disorder in preschool children
    Laurence L Greenhill
    Department of Psychiatry, New York State Psychiatric Institute, Unit 78, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Child Adolesc Psychiatr Clin N Am 17:347-66, ix. 2008
    ..Newly available data on the safety and efficacy of pharmacotherapy and psychosocial intervention for preschoolers who have ADHD may help clinicians make treatment decisions for these young children and their families...
  4. ncbi request reprint Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Desiree W Murray
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Child Adolesc Psychopharmacol 17:605-20. 2007
    ..To assess parent-teacher concordance on ratings of DSM-IV symptoms of attention-deficit/hyperactivity disorder (ADHD) in a sample of preschool children referred for an ADHD treatment study...
  5. ncbi request reprint Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Howard B Abikoff
    New York University Child Study Center, 215 Lexington Avenue, New York, NY 10016, USA
    J Child Adolesc Psychopharmacol 17:581-92. 2007
    ....
  6. ncbi request reprint Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Kelly Posner
    New York State Psychiatric Institute Columbia University, 1041 Riverside Drive, New York, NY 10032, USA
    J Child Adolesc Psychopharmacol 17:547-62. 2007
    ..The diagnosis and evaluation process will also be described...
  7. doi request reprint Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment
    Elizabeth Pappadopulos
    Columbia University, USA
    J Am Acad Child Adolesc Psychiatry 48:501-10. 2009
    ..Moreover, adherence measures often rely on parent report of medication use, and their validity and reliability are unknown...
  8. ncbi request reprint Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000
    Laurence L Greenhill
    New York State Psychiatric Institute, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:651-5. 2003
    ..To improve the methods for long-term assessment of drug-associated side effects and advance knowledge of the safety profile of psychotropic medications in children and adolescents...
  9. pmc A double-blind, placebo-controlled study of atomoxetine in young children with ADHD
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, 985581 Nebraska Medical Center, Omaha, NE 68198 5581, USA
    Pediatrics 127:e862-8. 2011
    ..To evaluate the efficacy and tolerability of atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in 5- and 6-year-old children...
  10. ncbi request reprint 3-year follow-up of the NIMH MTA study
    Peter S Jensen
    Center for the Advancement of Children s Mental Health, Unit 78, Columbia University NYSPI, 1051 Riverside Drive, New York, NY 10027, USA
    J Am Acad Child Adolesc Psychiatry 46:989-1002. 2007
    ..This report examines 36-month outcomes, 2 years after treatment by the study ended...
  11. ncbi request reprint Review of safety assessment methods used in pediatric psychopharmacology
    Laurence L Greenhill
    New York State Psychiatric Institute Columbia University, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:627-33. 2003
    ..Elicitation is an essential and critical step in ascertaining adverse events (AEs). This report reviews elicitation methods used in published clinical trials of psychopharmacological agents in children...
  12. ncbi request reprint Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects
    Brooke S G Molina
    Department of Psychiatry, University of Pittsburgh School of Medicine, 3811 O Hara Street, Pittsburgh, PA 15213, USA
    J Am Acad Child Adolesc Psychiatry 46:1028-40. 2007
    ....
  13. pmc Adolescent substance use in the multimodal treatment study of Attention-Deficit/Hyperactivity Disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication
    Brooke S G Molina
    Department of Psychiatry, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213, USA
    J Am Acad Child Adolesc Psychiatry 52:250-63. 2013
    ....
  14. ncbi request reprint Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder
    Karen C Wells
    Department of Psychiatry, Duke University Medical Center, Durham, NC, USA
    J Consult Clin Psychol 74:649-57. 2006
    ..The authors discuss the importance of changes in parenting behavior for families of children with ADHD and the need for reliable and objective measures in evaluating treatment outcome...
  15. ncbi request reprint Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD
    L Eugene Arnold
    Department of Psychiatry, Ohio State University, USA
    J Consult Clin Psychol 71:713-27. 2003
    ..Treatment for lower socioeconomic status minority children, especially if comorbid, should combine medication and behavioral treatment...
  16. ncbi request reprint Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial
    Cathryn A Galanter
    Columbia University New York State Psychiatric Institute, New York, New York 10032, USA
    J Child Adolesc Psychopharmacol 13:123-36. 2003
    ..Recent reports raise concern that children with attention deficit hyperactivity disorder (ADHD) and some manic symptoms may worsen with stimulant treatment. This study examines the response to methylphenidate in such children...
  17. pmc Neuroanatomical abnormalities in adolescents with attention-deficit/hyperactivity disorder
    Amy Garrett
    Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry, Stanford University, CA 94305 5795, USA
    J Am Acad Child Adolesc Psychiatry 47:1321-8. 2008
    ..However, findings are not always consistent, perhaps because of heterogeneous subject samples. Studying youths with documented familial ADHD provides an opportunity to examine a more homogeneous population...
  18. ncbi request reprint A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD
    Laurence L Greenhill
    Attention Deficit Disorder Research Program, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:1234-41. 2003
    ..To determine the pharmacokinetic and pharmacodynamic properties of once-daily versus twice-daily doses of Adderall...
  19. ncbi request reprint A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder
    Laurence L Greenhill
    New York State Psychiatric Institute, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 45:503-11. 2006
    ..To evaluate the efficacy and tolerability of modafinil in children and adolescents, ages 7 to 17, with attention-deficit/hyperactivity disorder (ADHD)...
  20. ncbi request reprint Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder
    Laurence L Greenhill
    Research Unit of Pediatric Psychopharmacology at the New York State Psychiatric Institute, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 45:817-23. 2006
    ..The efficacy and safety of dexmethylphenidate extended release (d-MPH-ER) was compared to placebo in pediatric patients with attention-deficit/hyperactivity disorder (ADHD)...
  21. ncbi request reprint Developing strategies for psychopharmacological studies in preschool children
    Laurence L Greenhill
    New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:406-14. 2003
    ..To identify the obstacles and special challenges-ethical, practical, scientific, and regulatory-faced by investigators who attempt to conduct psychopharmacological studies in preschoolers...
  22. ncbi request reprint A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder
    Laurence L Greenhill
    New York State Psychiatric Institute, New York, New York 10032, USA
    Pediatrics 109:E39. 2002
    ..To compare the efficacy, safety, and tolerability of once-daily administration of modified-release methylphenidate (MPH MR) with placebo in children with attention-deficit/hyperactivity disorder (ADHD)...
  23. doi request reprint Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder
    Loren J Sobel
    Department of Psychiatry, New York State Psychiatric Institute and the College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Psychiatry 167:977-86. 2010
    ..The authors examined the morphologic features of the basal ganglia nuclei (caudate, putamen, and globus pallidus) in children with ADHD...
  24. ncbi request reprint Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Robert L Findling
    Department of Psychiatry, University Hospitals Case Medical Center, Cleveland, Ohio 44106 5080, USA
    J Child Adolesc Psychopharmacol 17:433-45. 2007
    ..The objectives of this pilot study were to explore the changes in symptom severity, tolerability, and the pharmacodynamics of venlafaxine treatment in youths with attention-deficit/hyperactivity disorder (ADHD)...
  25. ncbi request reprint Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD
    B J Casey
    Sackler Institute, Weill Cornell Medical College of Cornell University, 1300 York Ave, Box 140, New York, NY 10021, USA
    Am J Psychiatry 164:1729-36. 2007
    ..Few studies have examined the role of white matter tracts between these structures or the extent to which white matter tract myelination and regularity correlate in family members with the disorder...
  26. doi request reprint Trends in office-based treatment of adults with stimulants in the United States
    Mark Olfson
    New York State Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA
    J Clin Psychiatry 74:43-50. 2013
    ..The authors investigated trends and patterns in stimulant treatment of adults visiting office-based medical practices in the United States...
  27. ncbi request reprint Assessment of safety in pediatric psychopharmacology
    Laurence L Greenhill
    New York State Psychiatric Institute, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:625-6. 2003
  28. ncbi request reprint The science of stimulant abuse
    Laurence L Greenhill
    New York State Psychiatric Institute, New York, NY 10032, USA
    Pediatr Ann 35:552-6. 2006
    ..Future products, employing novel methods that only allow the drug molecule to be available if ingested, should further increase the safety of these important therapeutic agents...
  29. ncbi request reprint Observed classroom behavior of children with ADHD: relationship to gender and comorbidity
    Howard B Abikoff
    New York University School of Medicine, New York, USA
    J Abnorm Child Psychol 30:349-59. 2002
    ....
  30. ncbi request reprint Pharmacological management of preschool ADHD
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha 68198 5581, and the Department of Psychiatry, New York State Psychiatric Institute, New York, USA
    J Am Acad Child Adolesc Psychiatry 45:115-8. 2006
  31. ncbi request reprint Pharmacotherapy of child and adolescent depression
    Carmen Moreno
    Division of Child Psychiatry, New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 74, New York, NY 10032, USA
    Child Adolesc Psychiatr Clin N Am 15:977-98, x. 2006
    ..The authors review data on efficacy and safety of antidepressants for the treatment of pediatric depression to provide treating clinicians with a basis on which to guide their treatment recommendations...
  32. ncbi request reprint Socioeconomic status as a moderator of ADHD treatment outcomes
    Ricardo Rieppi
    Department of Psychology, St Johns University, Jamaica, NY 11439, USA
    J Am Acad Child Adolesc Psychiatry 41:269-77. 2002
    ....
  33. ncbi request reprint ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD
    Jeffery N Epstein
    Department of Pediatrics, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    J Child Psychol Psychiatry 48:899-913. 2007
    ..Our objective was to examine functional brain abnormalities among youths and adults with ADHD and to examine the relations between these neurobiological abnormalities and response to stimulant medication...
  34. ncbi request reprint Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution
    Howard Abikoff
    Child and Adolescent Psychiatry, NYU Child Study Center, NYU School of Medicine, NY 10016, USA
    J Am Acad Child Adolesc Psychiatry 41:498-504. 2002
    ..Although the manual-based guidelines are especially applicable to multisite RCTs, many of the procedures in the ASAP Manual can apply to any treatment study in children...
  35. ncbi request reprint Psychopharmacological treatment for very young children: contexts and guidelines
    Mary Margaret Gleason
    Bradley Hasbro Research Center, Providence, RI 02903, USA
    J Am Acad Child Adolesc Psychiatry 46:1532-72. 2007
    ..The purpose of this effort is to promote responsible treatment of young children, recognizing that this will sometimes involve the use of medications...
  36. doi request reprint Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details
    James Swanson
    UCI Child Development Center, University of California, Irvine, Irvine, CA 92612, USA
    J Atten Disord 12:15-43. 2008
    ..To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles...
  37. ncbi request reprint Diagnosing and managing complicated ADHD
    Robert L Findling
    Department of Psychiatry and Pediatrics, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA
    J Clin Psychiatry 68:1963-70. 2007
  38. ncbi request reprint Which treatment for whom for ADHD? Moderators of treatment response in the MTA
    Elizabeth B Owens
    Institute of Human Development, University of California, Berkeley 94720 1690, USA
    J Consult Clin Psychol 71:540-52. 2003
    ..No predictors or moderators emerged for behavioral and community comparison treatments. The authors discuss conceptual and clinical implications of research on treatment moderators...
  39. ncbi request reprint Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Jaswinder K Ghuman
    University of Arizona, 1501 N Campbell Avenue, Tucson, AZ 85724, USA
    J Child Adolesc Psychopharmacol 17:563-80. 2007
    ..The aim of this study was to examine whether demographic or pretreatment clinical and social characteristics influenced the response to methylphenidate (MPH) in the Preschoolers with ADHD Treatment Study (PATS)...
  40. doi request reprint Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary
    James Swanson
    UCI Child Development Center, University of California, Irvine, Irvine, CA 92612, USA
    J Atten Disord 12:4-14. 2008
    ..To review the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published over the past decade as three sets of articles...
  41. ncbi request reprint Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Benedetto Vitiello
    Child and Adolescent Treatment and Preventive Intervention Research Branch, National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD 20892, USA
    J Child Adolesc Psychopharmacol 17:593-604. 2007
    ..The aim of this study was to examine immediate-release methylphenidate effectiveness during the 10-month open-label continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment Study (PATS)...
  42. pmc Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Biol Psychiatry 57:1442-51. 2005
    ..Despite growing interest in adult attention-deficit/hyperactivity disorder (ADHD), little is known about predictors of persistence of childhood cases into adulthood...
  43. ncbi request reprint Effects of stimulant medication on growth rates across 3 years in the MTA follow-up
    James M Swanson
    UCI Child Development Center, 19722 MacArthur Blvd, Irvine, CA 92612, USA
    J Am Acad Child Adolesc Psychiatry 46:1015-27. 2007
    ..To evaluate the hypothesis of stimulant medication effect on physical growth in the follow-up phase of the Multimodal Treatment Study of Children With ADHD...
  44. ncbi request reprint Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses
    James M Swanson
    UCI Child Development Center, 19722 MacArthur Blvd, Irvine, CA 92612, USA
    J Am Acad Child Adolesc Psychiatry 46:1003-14. 2007
    ....
  45. ncbi request reprint How can we improve the assessment of safety in child and adolescent psychopharmacology?
    Benedetto Vitiello
    Division of Services and Intervention Research, NIMH, Bethesda, MD 20982 9633, USA
    J Am Acad Child Adolesc Psychiatry 42:634-41. 2003
    ..To identify approaches to improving methods for assessing tolerability and safety of psychotropic medications in children and adolescents...
  46. ncbi request reprint A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study)
    James M Swanson
    University of California at Irvine Child Development Center, Irvine, California 92612, USA
    Pediatrics 113:e206-16. 2004
    ..According to this PK/PD model, clinical superiority is expected at any point in time for the formulation with the highest MPH plasma concentration...
  47. ncbi request reprint Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al
    R Julian Preston
    Cancer Lett 230:292-4. 2005
  48. ncbi request reprint Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation
    James M Swanson
    University of California at Irvine Child Development Center, 19722 MacArthur Boulevard, Irvine, CA 92627 4480, USA
    J Clin Psychiatry 67:137-47. 2006
    ..In addition, the effect of abrupt discontinuation of modafinil was evaluated in a 2-week observation period...
  49. ncbi request reprint Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures
    L Eugene Arnold
    The Ohio State University, Columbus, Ohio, USA
    J Abnorm Child Psychol 32:39-51. 2004
    ....
  50. ncbi request reprint International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions
    Stan Kutcher
    Dalhousie University Department of Psychiatry, QE II Health Sciences Centre, Abbie J Lane Building Suite 9212, 5909 Veterans Memorial Lane, Halifax, Nova Scotia, B3H 2E2, Canada
    Eur Neuropsychopharmacol 14:11-28. 2004
    ..Pharmacotherapy requires careful titration; full-day coverage is the suggested goal. Regular long-term follow-up is recommended...
  51. ncbi request reprint Assessing medication effects in the MTA study using neuropsychological outcomes
    Jeffery N Epstein
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    J Child Psychol Psychiatry 47:446-56. 2006
    ....
  52. ncbi request reprint Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults
    Laurence L Greenhill
    J Am Acad Child Adolesc Psychiatry 41:26S-49S. 2002
    ..Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed-salts amphetamine, and pemoline. It carries FDA indications for treatment of attention-deficit/hyperactivity disorder and narcolepsy...
  53. ncbi request reprint Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 45:919-27. 2006
    ....
  54. ncbi request reprint Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall
    James J McGough
    Department of Psychiatry and Biobehavioral Sciences, Division of Child and Adolescent Psychiatry, UCLA Neuropsychiatric Institute, Los Angeles, USA
    J Am Acad Child Adolesc Psychiatry 42:684-91. 2003
    ..To assess the pharmacokinetic (PK) properties of a single daily dose of Adderall (mixed amphetamine salts) and the extended-release formulation, SLI381 (ADDERALL XR), in pediatric attention-deficit/hyperactivity disorder (ADHD)...
  55. pmc The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Am J Psychiatry 163:716-23. 2006
    ..Despite growing interest in adult attention deficit hyperactivity disorder (ADHD), little is known about its prevalence or correlates...
  56. ncbi request reprint Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD
    James T McCracken
    Department of Psychiatry and Biobehavioral Sciences, Division of Child andAdolescent Psychiatry, UCLA Neuropsychiatric Institute, Los Angeles, CA 90024 1759, USA
    J Am Acad Child Adolesc Psychiatry 42:673-83. 2003
    ..Secondary objectives included examination of the time course, pharmacokinetic, and pharmacodynamic properties of SLI381...
  57. ncbi request reprint A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Child Adolesc Psychopharmacol 17:175-85. 2007
    ..The purpose of this study was to assess the effectiveness and tolerability of atomoxetine during acute treatment of attention-deficit/hyperactivity disorder (ADHD) in 5 and 6 year olds...
  58. ncbi request reprint Child and parent predictors of perceptions of parent--child relationship quality
    Alyson C Gerdes
    Marquette University, USA
    J Atten Disord 11:37-48. 2007
    ..The findings resolve a previous contradiction in the literature regarding the relationship between child depressive symptoms and parental perceptions of parent-child relationship quality...
  59. ncbi request reprint Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder
    Betsy Hoza
    Department of Psychological Sciences, Purdue University, West Lafayette, IN 47907 2081, USA
    J Clin Child Adolesc Psychol 34:74-86. 2005
    ..Results indicated that children from all groups remained significantly impaired in their peer relationships...
  60. ncbi request reprint Self-perceptions of competence in children with ADHD and comparison children
    Betsy Hoza
    Department of Psychological Sciences, Purdue University, West Lafayette, IN 47907 2081, USA
    J Consult Clin Psychol 72:382-91. 2004
    ..Examination by comorbidity subgroups revealed that children with ADHD inflated their self-perceptions the most in domains of greatest deficit. Gender effects also are reported...
  61. ncbi request reprint The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska 68198 5581, USA
    CNS Drugs 18:957-66. 2004
    ....
  62. ncbi request reprint Blindness of clinical evaluators, parents, and children in a placebo-controlled trial of fluvoxamine
    Benedetto Vitiello
    National Institute of Mental Health, Bethesda, Maryland 20892, USA
    J Child Adolesc Psychopharmacol 16:219-25. 2006
    ..The success of the masking procedures used in a double-blind, pediatric trial of fluvoxamine in children was examined...
  63. ncbi request reprint The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration
    Benedetto Vitiello
    Child and Adolescent Treatment and Preventive Intervention Research Branch, Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, Maryland, USA
    Biol Psychiatry 56:3-9. 2004
    ....
  64. ncbi request reprint Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    James M Swanson
    Child Development Center, University of California Irvine, 19722 MacArthur Boulevard, Irvine, CA 92612, USA
    J Child Adolesc Psychopharmacol 17:635-46. 2007
    ....
  65. pmc Assessment and prevention of head motion during imaging of patients with attention deficit hyperactivity disorder
    Jeffery N Epstein
    Department of Pediatrics, Cincinnati Children s Hospital Medical Center, 3333 Burnet Ave, ML 10006, Cincinnati, OH 45229, USA
    Psychiatry Res 155:75-82. 2007
    ..This study illustrates the need to (1) report data attrition due to head motion, (2) assess task-related motion, and (3) consider mock scanner training in functional imaging protocols...
  66. ncbi request reprint Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA
    James M Swanson
    Department of Pediatrics, University of California, Irvine 92612, USA
    J Abnorm Child Psychol 30:327-32. 2002
    ..Finally, we invite others to use the large and rich data set that will soon be available in the public domain, to perform secondary analyses to mine the meaning of the MTA and to evaluate theories of ADHD and response to treatments...